| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |